Therapeutic Innovations: Tyrosine Kinase Inhibitors in Cancer

Author： Dervisis Nikolaos   Klahn Shawna  

Publisher： MDPI

E-ISSN： 2306-7381|3|1|4-4

ISSN： 2306-7381

Source： Veterinary Sciences, Vol.3, Iss.1, 2016-01, pp. : 4-4

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Influence of Tyrosine Kinase Inhibitors on Hypertension and Nephrotoxicity in Metastatic Renal Cell Cancer Patients

By Semeniuk-Wojtaś Aleksandra   Lubas Arkadiusz   Stec Rafał   Szczylik Cezary   Niemczyk Stanisław  

International Journal of Molecular Sciences, Vol. 17, Iss. 12, 2016-12 ,pp. : 2073-2073

MDPI

Access to resources Recommend Favorite

The Role of Epidermal Growth Factor Receptor Mutations and Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in the Treatment of Lung Cancer

By Chang Shih-Chieh   Chang Cheng-Yu   Shih Jin-Yuan  

Cancers, Vol. 3, Iss. 2, 2011-06 ,pp. : 2667-2678

MDPI

Access to resources Recommend Favorite

Concurrent Autophagy Inhibition Overcomes the Resistance of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Human Bladder Cancer Cells

By Kang Minyong   Lee Kyoung-Hwa   Lee Hye Sun   Jeong Chang Wook   Kwak Cheol   Kim Hyeon Hoe   Ku Ja Hyeon  

International Journal of Molecular Sciences, Vol. 18, Iss. 2, 2017-02 ,pp. : 321-321

MDPI

Access to resources Recommend Favorite

Tyrosine Kinase Inhibitors as Antiangiogenic Drugs in Multiple Myeloma

By Ribatti Domenico  

Pharmaceuticals, Vol. 3, Iss. 4, 2010-04 ,pp. : 1225-1231

MDPI

Access to resources Recommend Favorite

Non-Invasive Methods to Monitor Mechanisms of Resistance to Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer: Where Do We Stand?

By Ulivi Paola  

International Journal of Molecular Sciences, Vol. 17, Iss. 7, 2016-07 ,pp. : 1186-1186

MDPI

Access to resources Recommend Favorite